# Donepezil

## Aricept 10mg orodispersible

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OARIE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Indications        | Treatment of mild to moderate dementia of the Alzheimer's type.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Dosing             | Initial， 5 mg orally once daily at bedtime; if suboptimal clinical response， may titrate to 10 mg orally once daily at 4 to 6 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Patients with a known hypersensitivity to donepezil HCl， piperidine derivatives or to any excipients used in Aricept. Use in children: Aricept is not recommended for use in children.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Nausea， diarrhea， insomnia， vomiting， muscle cramp， fatigue & anorexia. Syncopal episodes have been reported. Cardiovascular: Hypertension (3% )， Syncope (2% ) Endocrine metabolic: Weight decreased (3% to 5% ) Gastrointestinal: Diarrhea (5% to 15% )， Loss of appetite (2% to 8% )， Nausea (3% to 19% )， Vomiting (3% to 9% ) Hematologic: Contusion (2% )， Ecchymosis (4% to 5% ) Musculoskeletal: Cramp (3% to 8% )， Increased creatine kinase level (3% ) Neurologic: Asthenia (1% to 2% )， Dizziness (2% to 8% )， Headache (3% to 4% )， Insomnia (2% to 14% )， Somnolence (1% to 2% ) Psychiatric: Depression (2% to 3% )， Dream disorder (3% ) Renal: Urinary incontinence (1% to 3% ) Other: Fatigue (1% to 8% ) |
| Pregnancy          | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

